Cardiac autonomic neuropathy in patients with diabetes mellitus

被引:230
作者
Dimitropoulos, Gerasimos [1 ]
Tahrani, Abd A. [1 ,2 ]
Stevens, Martin J. [1 ,2 ]
机构
[1] Heart England Natl Hlth Serv Fdn Trust, Dept Diabet & Endocrinol, Birmingham B15 2TT, W Midlands, England
[2] Univ Birmingham, Ctr Endocrinol Diabet & Metab, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England
关键词
Diabetes mellitus; Cardiac; Cardiovascular; Autonomic; Neuropathy; Dysfunction; Cardiac autonomic neuropathy; Sympathetic; Parasympathetic; Heart rate variability; Spectral analysis; Diabetic cardiomyopathy; Postural hypotension;
D O I
10.4239/wjd.v5.i1.17
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac autonomic neuropathy (CAN) is an often overlooked and common complication of diabetes mellitus. CAN is associated with increased cardiovascular morbidity and mortality. The pathogenesis of CAN is complex and involves a cascade of pathways activated by hyperglycaemia resulting in neuronal ischaemia and cellular death. In addition, autoimmune and genetic factors are involved in the development of CAN. CAN might be subclinical for several years until the patient develops resting tachycardia, exercise intolerance, postural hypotension, cardiac dysfunction and diabetic cardiomyopathy. During its sub-clinical phase, heart rate variability that is influenced by the balance between parasympathetic and sympathetic tones can help in detecting CAN before the disease is symptomatic. Newer imaging techniques (such as scintigraphy) have allowed earlier detection of CAN in the pre-clinical phase and allowed better assessment of the sympathetic nervous system. One of the main difficulties in CAN research is the lack of a universally accepted definition of CAN; however, the Toronto Consensus Panel on Diabetic Neuropathy has recently issued guidance for the diagnosis and staging of CAN, and also proposed screening for CAN in patients with diabetes mellitus. A major challenge, however, is the lack of specific treatment to slow the progression or prevent the development of CAN. Lifestyle changes, improved metabolic control might prevent or slow the progression of CAN. Reversal will require combination of these treatments with new targeted therapeutic approaches. The aim of this article is to review the latest evidence regarding the epidemiology, pathogenesis, manifestations, diagnosis and treatment for CAN. (C) 2014 Baishideng Publishing Group Co., Limited. All rights reserved.
引用
收藏
页码:17 / 39
页数:23
相关论文
共 234 条
  • [51] Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
    Duckworth, William
    Abraira, Carlos
    Moritz, Thomas
    Reda, Domenic
    Emanuele, Nicholas
    Reaven, Peter D.
    Zieve, Franklin J.
    Marks, Jennifer
    Davis, Stephen N.
    Hayward, Rodney
    Warren, Stuart R.
    Goldman, Steven
    McCarren, Madeline
    Vitek, Mary Ellen
    Henderson, William G.
    Huang, Grant D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (02) : 129 - U62
  • [52] Diabetic neuropathy: Mechanisms to management
    Edwards, James L.
    Vincent, Andrea M.
    Cheng, Hsinlin T.
    Feldman, Eva L.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2008, 120 (01) : 1 - 34
  • [53] Medical therapy can improve the biological properties of the chronically failing heart - A new era in the treatment of heart failure
    Eichhorn, EJ
    Bristow, MR
    [J]. CIRCULATION, 1996, 94 (09) : 2285 - 2296
  • [54] Prevalence of autoantibodies to autonomic nervous tissue structures in Type 1 diabetes mellitus
    Ejskjaer, N
    Arift, S
    Dodds, W
    Zanone, MM
    Vergani, D
    Watkins, PJ
    Peakman, M
    [J]. DIABETIC MEDICINE, 1999, 16 (07) : 544 - 549
  • [55] EVALUATION OF DISTAL SYMMETRIC POLYNEUROPATHY: THE ROLE OF AUTONOMIC TESTING, NERVE BIOPSY, AND SKIN BIOPSY (AN EVIDENCE-BASED REVIEW)
    England, J. D.
    Gronseth, G. S.
    Franklin, G.
    Carter, G. T.
    Kinsella, L. J.
    Cohen, J. A.
    Asbury, A. K.
    Szigeti, K.
    Lupski, J. R.
    Latov, N.
    Lewis, R. A.
    Low, P. A.
    Fisher, M. A.
    Herrmann, D.
    Howard, J. F.
    Lauria, G.
    Miller, R. G.
    Polydefkis, M.
    Sumner, A. J.
    [J]. MUSCLE & NERVE, 2009, 39 (01) : 106 - 115
  • [56] Sudomotor function assessment as a screening tool for microvascular complications in type 2 diabetes
    Eranki, V. G.
    Santosh, R.
    Rajitha, K.
    Pillai, A.
    Sowmya, P.
    Dupin, J.
    Calvet, J. H.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 101 (03) : E11 - E13
  • [57] IMMEDIATE HEART-RATE RESPONSE TO STANDING - SIMPLE TEST FOR AUTONOMIC NEUROPATHY IN DIABETES
    EWING, DJ
    CAMPBELL, IW
    MURRAY, A
    NEILSON, JMM
    CLARKE, BF
    [J]. BRITISH MEDICAL JOURNAL, 1978, 1 (6106) : 145 - 147
  • [58] EWING DJ, 1980, Q J MED, V49, P95
  • [59] ASSESSMENT OF CARDIOVASCULAR EFFECTS IN DIABETIC AUTONOMIC NEUROPATHY AND PROGNOSTIC IMPLICATIONS
    EWING, DJ
    CAMPBELL, IW
    CLARKE, BF
    [J]. ANNALS OF INTERNAL MEDICINE, 1980, 92 (02) : 308 - 311
  • [60] Federation ID, 2012, IDF DIAB ATL 2012 UP